PCSK9 inhibitor (single-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCSK9 inhibitor (single-dose), covering 2025-07-24 to 2025-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study [Phase 4]